ATE83383T1 - Hochmolekulare prodrogenderivate von entzuendungshemmenden arzneimitteln. - Google Patents

Hochmolekulare prodrogenderivate von entzuendungshemmenden arzneimitteln.

Info

Publication number
ATE83383T1
ATE83383T1 AT89302051T AT89302051T ATE83383T1 AT E83383 T1 ATE83383 T1 AT E83383T1 AT 89302051 T AT89302051 T AT 89302051T AT 89302051 T AT89302051 T AT 89302051T AT E83383 T1 ATE83383 T1 AT E83383T1
Authority
AT
Austria
Prior art keywords
absent
residue
drug
formula
group
Prior art date
Application number
AT89302051T
Other languages
English (en)
Inventor
Claus Selch Larsen
Marianne Johansen
Elin Harboe
Peter Kurtzhals
Henning Peter Olesen
Original Assignee
Claus Selch Larsen
Marianne Johansen
Elin Harboe
Peter Kurtzhals
Henning Peter Olesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claus Selch Larsen, Marianne Johansen, Elin Harboe, Peter Kurtzhals, Henning Peter Olesen filed Critical Claus Selch Larsen
Application granted granted Critical
Publication of ATE83383T1 publication Critical patent/ATE83383T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT89302051T 1988-03-02 1989-03-01 Hochmolekulare prodrogenderivate von entzuendungshemmenden arzneimitteln. ATE83383T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK110188A DK110188D0 (da) 1988-03-02 1988-03-02 High molecular weight prodrug derivatives of antiinflammatory drugs
EP19890302051 EP0331471B1 (de) 1988-03-02 1989-03-01 Hochmolekulare Prodrogenderivate von entzündungshemmenden Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE83383T1 true ATE83383T1 (de) 1993-01-15

Family

ID=8101004

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89302051T ATE83383T1 (de) 1988-03-02 1989-03-01 Hochmolekulare prodrogenderivate von entzuendungshemmenden arzneimitteln.

Country Status (6)

Country Link
EP (1) EP0331471B1 (de)
JP (1) JPH04505334A (de)
AT (1) ATE83383T1 (de)
DE (1) DE68903852T2 (de)
DK (1) DK110188D0 (de)
WO (1) WO1989008119A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
RU2113221C1 (ru) * 1990-05-04 1998-06-20 Ииссум Рисерч Дивелопмент Компани оф дзе Хебрю Юниверсити оф Иеруcалим Фармацевтическая форма для введения лекарственного средства в ободочную кишку, способ введения лекарственного препарата и способ получения матриц для такой формы
AU659106B2 (en) * 1990-11-06 1995-05-11 Fgn, Inc. Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates
AU659107B2 (en) * 1990-11-06 1995-05-11 Fgn, Inc. Method for treating colonic polyps by the use of esters and amides of substituted fused ring phenyl acetic acids
AU650689B2 (en) * 1990-11-06 1994-06-30 Fgn, Inc. Esters and amides of substituted indenyl acetic acids
AU658373B2 (en) * 1990-11-06 1995-04-13 Fgn, Inc. Esters and amides of substituted pyrrole acetic acids
AU650914B2 (en) * 1990-11-06 1994-07-07 Fgn, Inc. Esters and amides of substituted phenyl acetic acids
CA2087452A1 (en) * 1991-05-20 1992-11-21 Toshiro Tsuda Steriod compound combined with polysaccharide
SE9103110D0 (sv) * 1991-10-24 1991-10-24 Kabi Pharmacia Ab New drug formulation
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
CA2274510C (en) * 1996-12-13 2010-02-16 Lescarden, Inc. Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine
US5902800A (en) * 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders
FR2809735B1 (fr) * 2000-06-02 2003-08-01 Biodex Composition pharmaceutique contenant au moins un polymere associe ou conjugue a au moins un sel d'un acide phenylalkycarboxylique, polymeres conjugues et leurs applications
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
US6897348B2 (en) 2001-12-19 2005-05-24 Kimberly Clark Worldwide, Inc Bandage, methods of producing and using same
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
RU2329274C2 (ru) 2002-09-11 2008-07-20 Фрезениус Каби Дойчланд Гмбх Способ получения производных гидроксиалкилкрахмала
ES2314238T3 (es) 2002-10-08 2009-03-16 Fresenius Kabi Deutschland Gmbh Conjugados de oligosacaridos farmaceuticamente activos.
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
CA2750725C (en) * 2004-01-07 2014-10-21 Seikagaku Corporation Spacer derivative for hyaluronic acid and non-steroidal anti-inflammatory drug residues
TWI417303B (zh) 2004-03-11 2013-12-01 Fresenius Kabi De Gmbh 經由還原胺化作用製得之羥烷基澱粉及蛋白質的接合物
DK1737428T3 (en) 2004-03-31 2017-10-09 Univ Utah Res Found MACROMOLECULAR ADMINISTRATION SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES
EP2070950A1 (de) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkylstärkederivate und deren Herstellungsverfahren
US20210023017A1 (en) * 2018-03-16 2021-01-28 University Of Massachusetts Yeast cell wall particle encapsulation of biodegradable pro-payloads
CN116891540A (zh) * 2018-03-22 2023-10-17 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
WO2021060395A1 (ja) * 2019-09-25 2021-04-01 持田製薬株式会社 徐放性医薬組成物
WO2021060351A1 (ja) * 2019-09-25 2021-04-01 持田製薬株式会社 ＮＳＡＩＤｓ結合アルギン酸誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003990A (en) * 1972-06-29 1977-01-18 Societe Anonyme Dite: L'oreal Anti-inflammatory polymers, pharmaceutical compositions containing the same and process for producing said polymers
SE431937B (sv) * 1979-01-29 1984-03-12 Perstorp Ab Salicylazosulfapyridinhaltigt medicinskt preparat
EP0019403B1 (de) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Arzneimittelträger auf der Basis von Hydroxyalkyl-Stärke
GB8328917D0 (en) * 1983-10-28 1983-11-30 Fisons Plc Blood substitute
IT1203814B (it) * 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico

Also Published As

Publication number Publication date
DE68903852D1 (de) 1993-01-28
EP0331471A1 (de) 1989-09-06
JPH04505334A (ja) 1992-09-17
WO1989008119A1 (en) 1989-09-08
EP0331471B1 (de) 1992-12-16
DK110188D0 (da) 1988-03-02
DE68903852T2 (de) 1993-06-17

Similar Documents

Publication Publication Date Title
ATE83383T1 (de) Hochmolekulare prodrogenderivate von entzuendungshemmenden arzneimitteln.
ES2173096T3 (es) Composicion farmaceutica peletizada.
AU728826B2 (en) Compositions for treating and preventing arterial thrombosis and use of a factor Xa inhibitor on its own and/or combined with a platelet antiaggregating agent
KR920012113A (ko) 펩타이드 유도체의 사용방법
KR890009376A (ko) 분무 건조된 이부프로펜
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
ATE4903T1 (de) 1-, 6- und 2-substituierte 1-carba-2-penem-3carbons[ure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE69413857D1 (de) Arzneizusammensetzungen enthaltend Nanokapseln
KR890011823A (ko) 벤조일 페닐아세트산 유도체 약제 조성물
RO108220B1 (ro) Preparate farmaceutice,pentru combaterea carceilor musculari si procedeu de obtinere a acestora
TW200519129A (en) Biodegradable hyaluronic acid derivative, biodegradable polymeric micelle composition, and pharmaceutical or bioactive composition containing the micelle composition
KR900011784A (ko) α, D-글루코푸라노오스 또는 α,D-알로푸라노오스 유도체와 중간체 및 그의 제조방법
JPH08505161A (ja) 自己架橋ゲランガム
EP0647616A4 (de) Zink-tranexamat derivat.
CA2079205A1 (en) Use of Hyaluronic Acid and Forms to Prevent Arterial Restenosis
JPH07157431A (ja) 安定なプロスタグランジンｅ製剤
ATE151770T1 (de) Cephalosporinverbindungen und deren herstellung
JP2671381B2 (ja) 点眼剤
FI892685A0 (fi) Menetelmä uusien, sytostaattisesti vaikuttavien antrasykliinijohdannaisten valmistamiseksi
KR870006081A (ko) 신규 16,17-아세탈치환 프레그난 21-오익 에시드유도체 및 그의 제조방법
US3594482A (en) Method of treating a pathological fibrinolytic state in mammals
JPS57209272A (en) Indirubin derivative and antitumor agent containing the same
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
JPH03251526A (ja) 糖尿病依存型自己免疫疾患治療、予防用薬剤